Varenicline tartrate is a prescription medicine that was developed by Pfizer, Inc. specifically to help people quit smoking. Marketed as Chantix, it works on two levels
First, Chantix partially activates sites in the brain known as nicotinic acetylcholine receptors that are affected by nicotine.